Article

Bio-tests for Schizophrenia And Depression

The race to patent bio-tests for schizophrenia and depression: some say this initiative is destined to fail.

Recent articles by Arline Kaplan and Hagop Asiskal, MD, highlight the race to patent bio-tests for schizophrenia and depression. Dr Max Fink continues the discussion in his commentary; he contends the DSM divisions serve patients and doctors poorly. Tell us what you think.
 

Related Videos
sc
schizophrenia
clozapine
brain
cognition
clock
clozapine
steering wheel
schizophrenia
Christoph U. Correll
Related Content
Jesse H. Wright, MD, PhD
April 17th 2025

Reflections on 50 Years in Psychiatry: An Interview with Jesse H. Wright, MD, PhD

Mehak Pahwa, MBBS Iyanjesu Adereti, MBBCh Jesse H. Wright, MD, PhD
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
road choice
April 15th 2025

The Slow Road to Psychosis

Husein Hijazi, MD Nidal Moukaddam, MD, PhD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
pregnant
April 11th 2025

Examining a Case of Acute Late-Pregnancy Psychosis: How Best to Coordinate Care

Cecilia A. Westbrook, MD, PhD Meredith Spada, MD Elizabeth M. Hovis, MD Jacob Larkin, MD Alexandra Nicholas, MD Luke Swider, MD Jonathan Yadlosky, MD Joseph S. DeRenzo, MD Adam P. Dunmore, MD Jennifer L. Kloesz, MD, FAAP Linda Dudas, RNC, MSN, CNL John Silipigni, MSW, MBA Priya Gopalan, MD
antidepressants
April 8th 2025

No, Your Patients Are Not Wrong: Sometimes Antidepressant Side Effects Do Not Get Better

Colin Xu, PhD Thomas T. Kim, PhD
© 2025 MJH Life Sciences

All rights reserved.